Latest Tokyo Brief coverage on SEIKAGAKU CORPORATION, tracking filings, financial news, and market signals from Japan.
TSE:4548
Seikagaku Corporation now expects a ¥1.8bn net loss for the year to March 2027, reversing a forecast ¥2.3bn profit, and has cut its full-year dividend from ¥30 to ¥20 per share after telling investors royalty income will fall sharply.
Seikagaku's Complete Response Letter from the FDA flags unresolved deficiencies at its active-ingredient plant and new problems at a contract formulator for SI-6603, with no concerns raised about the drug's efficacy or safety data and no resubmission date given.
Current holdings disclosed by tracked funds.
| Fund | NAV weight | Holdings as of |
|---|---|---|
| NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF | 0.05% | 30 Sept 2026 |
| The Japanese Small Company Series | 0.02% | 31 Jul 2026 |
| PBR Improvement over 1x ETF | 0.01% | 23 Oct 2026 |
| MAXIS TOPIX Ex-Financials ETF | 0% | 23 Oct 2026 |
| NZAM ETF TOPIX Ex-Financials | 0% | 23 Oct 2026 |
| NZAM ETF TOPIX | 0% | 23 Oct 2026 |
| iShares Core TOPIX ETF | 0% | 23 Oct 2026 |
| NEXT FUNDS TOPIX Exchange Traded Fund | 0% | 30 Sept 2026 |
| Listed Index Fund TOPIX **** | 0% | 23 Oct 2026 |
| MAXIS TOPIX ETF | 0% | 23 Oct 2026 |
| SMDAM TOPIX ETF | 0% | 23 Oct 2026 |
| Nissay ETF TOPIX (Quarterly settlement type) | 0% | 23 Oct 2026 |
| iFreeETF TOPIX (Yearly Dividend Type) **** | 0% | 23 Oct 2026 |
| One ETF TOPIX | 0% | 23 Oct 2026 |
| iFreeETF TOPIX (Quarterly Dividend Type) **** | 0% | 23 Oct 2026 |
| Listed Index Fund TOPIX Ex-Financials **** | 0% | 23 Oct 2026 |
| NZAM ETF S&P/JPX Carbon Efficient Index | 0% | 23 Oct 2026 |